GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CytomX Therapeutics Inc (STU:6C1) » Definitions » Other Stockholders Equity

CytomX Therapeutics (STU:6C1) Other Stockholders Equity : €-0.0 Mil (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is CytomX Therapeutics Other Stockholders Equity?

CytomX Therapeutics's Other Stockholders Equity for the quarter that ended in Mar. 2024 was €-0.0 Mil.

CytomX Therapeutics's quarterly Other Stockholders Equity increased from Sep. 2023 (€0.0 Mil) to Dec. 2023 (€0.0 Mil) but then declined from Dec. 2023 (€0.0 Mil) to Mar. 2024 (€-0.0 Mil).

CytomX Therapeutics's annual Other Stockholders Equity increased from Dec. 2021 (€0.0 Mil) to Dec. 2022 (€0.0 Mil) but then declined from Dec. 2022 (€0.0 Mil) to Dec. 2023 (€0.0 Mil).


CytomX Therapeutics Other Stockholders Equity Historical Data

The historical data trend for CytomX Therapeutics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CytomX Therapeutics Other Stockholders Equity Chart

CytomX Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CytomX Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

CytomX Therapeutics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


CytomX Therapeutics Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of CytomX Therapeutics's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


CytomX Therapeutics (STU:6C1) Business Description

Traded in Other Exchanges
Address
151 Oyster Point Boulevard, Suite 400, South San Francisco, CA, USA, 94080
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platform. The company probody technology platform to create proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

CytomX Therapeutics (STU:6C1) Headlines

No Headlines